Evotec SE provides update on cyber attack
Business continuity upheld at all global sites after cyber attack – Forensic examination ongoing with external experts – Evotec SE today announced an update on…
Learn more
Ad hoc: Cyber Attack on Evotec
Hamburg, Germany, – Evotec SE announces that on 06 April, 2023 a cyber attack occurred on Evotec‘s IT systems. As a result, the systems were…
Updated FDA Guidance on Continuous Manufacturing of Drug Substances and Drug Products
Full FDA guidance on Q13 Continuous Manufacturing available for download
A Year of Growth and Influence:
Our Biomanufacturing Highlights 2022
Just – Evotec Biologics’ 2022 Highlights
How an Integrated, Continuous, Intensified Approach for Manufacturing Biologics Provides Productivity and Quality Benefits
Read the article about how to rapidly develop and manufacture mAb-based therapeutics
Interview CPHI Pharma Awards 2022
Read the interview with Randal Bass, EVP Process Design & Biotherapeutic Operations at Just-Evotec Biologics
Continuous bioprocessing set to revolutionize cGMP manufacturing of biologics
Read the article describing the latest trends in the biopharmaceutical industry
Intensified continuous bioprocessing supports industry trends
Read the article on our continuous bioprocess platform used at J.POD
Success & Challenges in AI-driven Antibody Discovery
Watch the recorded presentation with Josh Smith, Principal Scientist, Molecular Design at PEGS Boston 2023
BioProcess Insider Interview with Jon Gunther at BIO 2022
Watch the recorded interview with Jon Gunther, VP Business Development, and Dan Stanton, Co-founder and Editor at BioProcess Insider at BIO International Convention 2022..
Advancing Process Design for Accessible mAb-based Therapeutics
Read the article about how to rapidly develop and manufacture mAb-based therapeutics
Why Early mAb Sequence Optimization can Improve Developability and Reduce Costs
Read the article on why early mAb optimization might be right for your project.